We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+2.33%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$152B
AUM Growth
+$4.77B
Cap. Flow
+$2.89B
Cap. Flow %
1.9%
Top 10 Hldgs %
26.78%
Holding
4,133
New
185
Increased
1,882
Reduced
1,701
Closed
184

Sector Composition

Rank Sector Weight
1 Technology 17.11%
2 Financials 8.61%
3 Healthcare 7.69%
4 Industrials 6.49%
5 Consumer Discretionary 5.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRKS icon
2526
United Parks & Resorts
PRKS
$2.01B
$1.16M ﹤0.01%
21,379
+2,435
+13% +$127K
AM icon
2527
Antero Midstream
AM
$10.5B
$1.16M ﹤0.01%
78,766
-8,264
-9% -$119K
JELD icon
2528
JELD-WEN Holding
JELD
$164M
$1.16M ﹤0.01%
86,160
-9,123
-10% -$152K
XHE icon
2529
State Street SPDR S&P Health Care Equipment ETF
XHE
$169M
$1.16M ﹤0.01%
13,747
-417
-3% -$35.4K
FFBC icon
2530
First Financial Bancorp
FFBC
$3.6B
$1.16M ﹤0.01%
52,086
-3,128
-6% -$69.1K
JVAL icon
2531
JPMorgan US Value Factor ETF
JVAL
$876M
$1.16M ﹤0.01%
28,313
+1,271
+5% +$51.6K
BMAR icon
2532
Innovator US Equity Buffer ETF March
BMAR
$255M
$1.16M ﹤0.01%
26,789
-610
-2% -$25.5K
SIVR icon
2533
abrdn Physical Silver Shares ETF
SIVR
$4.47B
$1.16M ﹤0.01%
41,495
+21,467
+107% +$591K
GSG icon
2534
iShares S&P GSCI Commodity-Indexed Trust
GSG
$932M
$1.15M ﹤0.01%
51,986
+585
+1% +$13K
CVSA
2535
Covista Inc
CVSA
$4.36B
$1.15M ﹤0.01%
16,878
+22
+0.1% +$1.29K
MAMA icon
2536
Mama's Creations
MAMA
$826M
$1.15M ﹤0.01%
170,660
-4,840
-3% -$29.5K
CORP icon
2537
PIMCO Investment Grade Corporate Bond Index Exchange-Traded Fund
CORP
$1.58B
$1.14M ﹤0.01%
12,009
-704
-6% -$66.6K
NOK icon
2538
Nokia
NOK
$59B
$1.14M ﹤0.01%
301,720
-30,152
-9% -$111K
DRIV icon
2539
Global X Autonomous & Electric Vehicles ETF
DRIV
$394M
$1.14M ﹤0.01%
48,531
-18,497
-28% -$445K
AOSL icon
2540
Alpha and Omega Semiconductor
AOSL
$916M
$1.14M ﹤0.01%
30,497
+6,505
+27% +$172K
CERT icon
2541
Certara
CERT
$1.24B
$1.14M ﹤0.01%
82,127
-643
-0.8% -$10.6K
APLS
2542
DELISTED
Apellis Pharmaceuticals
APLS
$1.13M ﹤0.01%
29,582
+10,627
+56% +$481K
CX icon
2543
Cemex
CX
$16B
$1.13M ﹤0.01%
176,978
-5,577
-3% -$42.7K
JRI icon
2544
Nuveen Real Asset Income & Growth Fund
JRI
$349M
$1.13M ﹤0.01%
92,907
-4,122
-4% -$47.8K
IBTH icon
2545
iShares iBonds Dec 2027 Term Treasury ETF
IBTH
$2.28B
$1.13M ﹤0.01%
51,208
+28,055
+121% +$616K
RLTY icon
2546
Cohen & Steers Real Estate Opportunities and Income Fund
RLTY
$261M
$1.13M ﹤0.01%
79,411
+9,602
+14% +$132K
RVTY icon
2547
Revvity
RVTY
$13.1B
$1.13M ﹤0.01%
10,771
+2,957
+38% +$314K
EMBJ
2548
Embraer S.A. ADS
EMBJ
$13.2B
$1.13M ﹤0.01%
43,687
-12,360
-22% -$335K
IONS icon
2549
Ionis Pharmaceuticals
IONS
$9.39B
$1.12M ﹤0.01%
23,573
-88,981
-79% -$3.65M
INDY icon
2550
iShares S&P India Nifty 50 Index Fund
INDY
$562M
$1.12M ﹤0.01%
20,920
+2,334
+13% +$119K

Similar funds

Raymond James & Associates's Q2 2024 Portfolio in Review

As of Q2 2024, Raymond James & Associates held 4,133 positions worth $152B, up 3.2% from $148B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Raymond James & Associates's Q2 2024 filing shows 185 new, 1,882 increased, 1,701 reduced and 184 closed positions. Its largest new stake was Solventum: 321,226 shares worth $17M. The largest sale was State Street Health Care Select Sector SPDR ETF, an estimated $157M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q2 2024 buy was Solventum: 321,226 shares worth $17M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q2 2024, an estimated $255M increase.
  • Raymond James & Associates's biggest Q2 2024 reduction was State Street Health Care Select Sector SPDR ETF, cutting an estimated $157M.
  • Raymond James & Associates fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $110M.
  • Raymond James & Associates's ten largest holdings make up 27% of its $152B portfolio in Q2 2024.
  • Raymond James & Associates opened 185 new positions and closed 184 in Q2 2024.
  • Raymond James & Associates's portfolio value rose 3.2% quarter-over-quarter to $152B.

Based on Raymond James & Associates's 13F filing for Q2 2024, filed 19 Jul 2024.